Clinical trials: sponsored by InSightec

Uterine Leiomyoma, Uterine Fibroids

MR Guided Focused Ultrasound Treatment of Uterine Fibroids With Enhanced Sonication

• Completed
• Age: 18 years and older
• Phase 3
• Medical device
• Results posted

This is a phase 3 study to determine the safety of the new features to the FDA approved ExAblate device using a new method to ablate fibroids deemed Enhanced Sonication.

Trial name

NCT00365989

Testing

ExAblate Enhanced Sonication

Where

5 sites in United States, Canada

Volunteers

50 people, healthy volunteers welcome

Sponsor

InSightec